{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:50:16Z","timestamp":1792691416100,"version":"4.5.0"},"reference-count":195,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T00:00:00Z","timestamp":1741996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-025-03172-2","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T11:47:46Z","timestamp":1742039266000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Omega-6 polyunsaturated fatty acids and their metabolites: a potential targeted therapy for pulmonary hypertension"],"prefix":"10.1186","volume":"26","author":[{"given":"Jiayao","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunlian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,15]]},"reference":[{"key":"3172_CR1","doi-asserted-by":"crossref","unstructured":"Humbert M, Guignabert C, Bonnet S, Dorfm\u00fcller P, Klinger JR, Nicolls MR, Olschewski AJ, Pullamsetti SS, Schermuly RT, Stenmark KR, Rabinovitch M. Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives. 2019.","DOI":"10.1183\/13993003.01887-2018"},{"key":"3172_CR2","doi-asserted-by":"crossref","unstructured":"Simonneau G, Montani D, Celermajer DS, Denton CP, Gatzoulis MA, Krowka M, Williams PG, Souza R. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. 2019.","DOI":"10.1183\/13993003.01913-2018"},{"key":"3172_CR3","doi-asserted-by":"crossref","unstructured":"Mandras SA, Mehta HS, Vaidya A. Pulmonary Hypertension: A Brief Guide for Clinicians. 2020; pp. 1978\u20131988.","DOI":"10.1016\/j.mayocp.2020.04.039"},{"key":"3172_CR4","doi-asserted-by":"crossref","unstructured":"Gabbs M, Leng S, Devassy JG, Monirujjaman M, Aukema HM. Advances in Our Understanding of Oxylipins Derived from Dietary PUFAs. 2015; pp. 513\u2013540.","DOI":"10.3945\/an.114.007732"},{"key":"3172_CR5","doi-asserted-by":"crossref","unstructured":"Larsson N, Lundstr\u00f6m SL, Pinto R, Rankin G, Karimpour M, Blomberg A, Sandstr\u00f6m T, Pourazar J, Trygg J, Behndig AF, Wheelock CE, Nording ML. Lipid mediator profiles differ between lung compartments in asthmatic and healthy humans. Eur Respir J 2014: 43(2): 453\u201363.","DOI":"10.1183\/09031936.00209412"},{"key":"3172_CR6","doi-asserted-by":"crossref","unstructured":"Bazinet RP, Lay\u00e9 S. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci 2014: 15(12): 771\u201385.","DOI":"10.1038\/nrn3820"},{"key":"3172_CR7","doi-asserted-by":"publisher","first-page":"102160","DOI":"10.1016\/j.plefa.2020.102160","volume":"160","author":"Y Du","year":"2020","unstructured":"Du Y, Taylor CG, Aukema HM, Zahradka P. Role of Oxylipins generated from dietary PUFAs in the modulation of endothelial cell function. Prostaglandins Leukot Essent Fat Acids. 2020;160:102160.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"3172_CR8","doi-asserted-by":"publisher","first-page":"j5492","DOI":"10.1136\/bmj.j5492","volume":"360","author":"T Thenappan","year":"2018","unstructured":"Thenappan T, Ormiston ML, Ryan JJ, Archer SL. Pulmonary arterial hypertension: pathogenesis and clinical management. BMJ. 2018;360:j5492.","journal-title":"BMJ"},{"issue":"2","key":"3172_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","volume":"109","author":"R Budhiraja","year":"2004","unstructured":"Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation. 2004;109(2):159\u201365.","journal-title":"Circulation"},{"issue":"8s","key":"3172_CR10","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1016\/j.amjcard.2017.06.012","volume":"120","author":"JR Klinger","year":"2017","unstructured":"Klinger JR, Kadowitz PJ. The nitric oxide pathway in pulmonary vascular disease. Am J Cardiol. 2017;120(8s):S71\u20139.","journal-title":"Am J Cardiol"},{"issue":"6","key":"3172_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1177\/10742484211014162","volume":"26","author":"M Reinero","year":"2021","unstructured":"Reinero M, Beghetti M, Tozzi P, Segesser LKV, Samaja M, Milano G. Nitric Oxide-cGMP pathway modulation in an experimental model of hypoxic pulmonary hypertension. J Cardiovasc Pharmacol Ther. 2021;26(6):665\u201376.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"1","key":"3172_CR12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bcp.2012.03.012","volume":"84","author":"BJ Whittle","year":"2012","unstructured":"Whittle BJ, Silverstein AM, Mottola DM, Clapp LH. Binding and activity of the Prostacyclin receptor (IP) agonists, treprostinil and Iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist. Biochem Pharmacol. 2012;84(1):68\u201375.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"3172_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1124\/pr.111.004770","volume":"64","author":"BH Majed","year":"2012","unstructured":"Majed BH, Khalil RA. Molecular mechanisms regulating the vascular Prostacyclin pathways and their adaptation during pregnancy and in the newborn. Pharmacol Rev. 2012;64(3):540\u201382.","journal-title":"Pharmacol Rev"},{"issue":"2","key":"3172_CR14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1164\/ajrccm.164.2.2010150","volume":"164","author":"Y Hoshikawa","year":"2001","unstructured":"Hoshikawa Y, Voelkel NF, Gesell TL, Moore MD, Morris KG, Alger LA, Narumiya S, Geraci MW. Prostacyclin receptor-dependent modulation of pulmonary vascular remodeling. Am J Respir Crit Care Med. 2001;164(2):314\u20138.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6 Suppl","key":"3172_CR15","doi-asserted-by":"publisher","first-page":"s572","DOI":"10.1378\/chest.128.6_suppl.572S-a","volume":"128","author":"SM Golembeski","year":"2005","unstructured":"Golembeski SM, West J, Tada Y, Fagan KA. Interleukin-6 causes mild pulmonary hypertension and augments hypoxia-induced pulmonary hypertension in mice. Chest. 2005;128(6 Suppl):s572\u20133.","journal-title":"Chest"},{"issue":"11","key":"3172_CR16","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1161\/CIRCULATIONAHA.113.004136","volume":"128","author":"L Zhao","year":"2013","unstructured":"Zhao L, Ashek A, Wang L, Fang W, Dabral S, Dubois O, Cupitt J, Pullamsetti SS, Cotroneo E, Jones H, Tomasi G, Nguyen QD, Aboagye EO, El-Bahrawy MA, Barnes G, Howard LS, Gibbs JS, Gsell W, He JG, Wilkins MR. Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments. Circulation. 2013;128(11):1214\u201324.","journal-title":"Circulation"},{"issue":"15","key":"3172_CR17","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1161\/CIRCULATIONAHA.116.023171","volume":"134","author":"M Li","year":"2016","unstructured":"Li M, Riddle S, Zhang H, D\u2019Alessandro A, Flockton A, Serkova NJ, Hansen KC, Moldovan R, McKeon BA, Frid M, Kumar S, Li H, Liu H, Ca\u00e1novas A, Medrano JF, Thomas MG, Iloska D, Plecit\u00e1-Hlavat\u00e1 L, Je\u017eek P, Pullamsetti S, Fini MA, El Kasmi KC, Zhang Q, Stenmark KR. Metabolic reprogramming regulates the proliferative and inflammatory phenotype of adventitial fibroblasts in pulmonary hypertension through the transcriptional corepressor C-Terminal binding Protein-1. Circulation. 2016;134(15):1105\u201321.","journal-title":"Circulation"},{"issue":"3","key":"3172_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1164\/rccm.201108-1536PP","volume":"185","author":"RM Tuder","year":"2012","unstructured":"Tuder RM, Davis LA, Graham BB. Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension. Am J Respir Crit Care Med. 2012;185(3):260\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"3172_CR19","doi-asserted-by":"publisher","first-page":"L870","DOI":"10.1152\/ajplung.00283.2017","volume":"315","author":"MR La Frano","year":"2018","unstructured":"La Frano MR, Fahrmann JF, Grapov D, Pedersen TL, Newman JW, Fiehn O, Underwood MA, Mestan K, Steinhorn RH, Wedgwood S. Umbilical cord blood metabolomics reveal distinct signatures of dyslipidemia prior to bronchopulmonary dysplasia and pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol. 2018;315(5):L870\u201381.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3172_CR20","doi-asserted-by":"crossref","unstructured":"Bowers R, Cool C, Murphy RC, Tuder RM, Hopken MW, Flores SC, Voelkel NF. Oxidative stress in severe pulmonary hypertension. pp. 764\u20139.","DOI":"10.1164\/rccm.200301-147OC"},{"key":"3172_CR21","doi-asserted-by":"crossref","unstructured":"Al-Naamani N, Sagliani KD, Dolnikowski GG, Warburton RR, Toksoz D, Kayyali U, Hill NS, Fanburg BL, Roberts KE, Preston IR. Plasma 12- and 15-hydroxyeicosanoids are predictors of survival in pulmonary arterial hypertension. 2016; pp. 224\u201333.","DOI":"10.1086\/686311"},{"key":"3172_CR22","doi-asserted-by":"crossref","unstructured":"Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. An imbalance between the excretion of thromboxane and Prostacyclin metabolites in pulmonary hypertension. 1992; pp. 70\u20135.","DOI":"10.1056\/NEJM199207093270202"},{"issue":"1","key":"3172_CR23","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0090-6980(79)80022-2","volume":"18","author":"P Polgar","year":"1979","unstructured":"Polgar P, Taylor L, Downing D. Unsaturated fatty acid effect on Cyclic AMP levels in human embryo lung fibroblasts. Prostaglandins. 1979;18(1):43\u201352.","journal-title":"Prostaglandins"},{"issue":"2","key":"3172_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/0021-9150(93)90270-5","volume":"103","author":"S Ramasamy","year":"1993","unstructured":"Ramasamy S, Boissonneault GA, Lipke DW, Hennig B. Proteoglycans and endothelial barrier function: effect of Linoleic acid exposure to Porcine pulmonary artery endothelial cells. Atherosclerosis. 1993;103(2):279\u201390.","journal-title":"Atherosclerosis"},{"issue":"3","key":"3172_CR25","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/ajcn\/63.3.322","volume":"63","author":"B Hennig","year":"1996","unstructured":"Hennig B, Toborek M, Joshi-Barve S, Barger SW, Barve S, Mattson MP, McClain CJ. Linoleic acid activates nuclear transcription factor-kappa B (NF-kappa B) and induces NF-kappa B-dependent transcription in cultured endothelial cells. Am J Clin Nutr. 1996;63(3):322\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"3172_CR26","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1053\/meta.2000.7736","volume":"49","author":"B Hennig","year":"2000","unstructured":"Hennig B, Meerarani P, Ramadass P, Watkins BA, Toborek M. Fatty acid-mediated activation of vascular endothelial cells. Metabolism. 2000;49(8):1006\u201313.","journal-title":"Metabolism"},{"issue":"5","key":"3172_CR27","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1161\/01.ATV.2.5.380","volume":"2","author":"TL Kaduce","year":"1982","unstructured":"Kaduce TL, Spector AA, Bar RS. Linoleic acid metabolism and prostaglandin production by cultured bovine pulmonary artery endothelial cells. Arteriosclerosis. 1982;2(5):380\u20139.","journal-title":"Arteriosclerosis"},{"issue":"4","key":"3172_CR28","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1053\/meta.2003.50087","volume":"52","author":"P Meerarani","year":"2003","unstructured":"Meerarani P, Smart EJ, Toborek M, Boissonneault GA, Hennig B. Cholesterol attenuates Linoleic acid-induced endothelial cell activation. Metabolism. 2003;52(4):493\u2013500.","journal-title":"Metabolism"},{"issue":"10","key":"3172_CR29","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/jn\/133.10.3058","volume":"133","author":"P Meerarani","year":"2003","unstructured":"Meerarani P, Reiterer G, Toborek M, Hennig B. Zinc modulates PPARgamma signaling and activation of Porcine endothelial cells. J Nutr. 2003;133(10):3058\u201364.","journal-title":"J Nutr"},{"issue":"5","key":"3172_CR30","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1194\/jlr.M300497-JLR200","volume":"45","author":"V Saraswathi","year":"2004","unstructured":"Saraswathi V, Wu G, Toborek M, Hennig B. Linoleic acid-induced endothelial activation: role of calcium and peroxynitrite signaling. J Lipid Res. 2004;45(5):794\u2013804.","journal-title":"J Lipid Res"},{"issue":"4 Pt 1","key":"3172_CR31","doi-asserted-by":"publisher","first-page":"C990","DOI":"10.1152\/ajpcell.1994.266.4.C990","volume":"266","author":"LL Stoll","year":"1994","unstructured":"Stoll LL, Morland MR, Spector AA. 13-HODE increases intracellular calcium in vascular smooth muscle cells. Am J Physiol. 1994;266(4 Pt 1):C990\u2013996.","journal-title":"Am J Physiol"},{"issue":"4","key":"3172_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0049-3848(91)90151-L","volume":"62","author":"MA Tloti","year":"1991","unstructured":"Tloti MA, Moon DG, Weston LK, Kaplan JE. Effect of 13-hydroxyoctadeca-9,11-dienoic acid (13-HODE) on thrombin induced platelet adherence to endothelial cells in vitro. Thromb Res. 1991;62(4):305\u201317.","journal-title":"Thromb Res"},{"issue":"1\u20132","key":"3172_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0021-9150(95)05702-1","volume":"120","author":"S Ramasamy","year":"1996","unstructured":"Ramasamy S, Lipke DW, Boissonneault GA, Guo H, Hennig B. Oxidized lipid-mediated alterations in proteoglycan metabolism in cultured pulmonary endothelial cells. Atherosclerosis. 1996;120(1\u20132):199\u2013208.","journal-title":"Atherosclerosis"},{"key":"3172_CR34","doi-asserted-by":"crossref","unstructured":"Ziboh VA, Yun M, Hyde DM, Giri SN. gamma-Linolenic acid-containing diet attenuates bleomycin-induced lung fibrosis in hamsters. 1997; pp. 759\u201367.","DOI":"10.1007\/s11745-997-0097-x"},{"key":"3172_CR35","doi-asserted-by":"crossref","unstructured":"Umar S, Nadadur RD, Li J, Maltese F, Partownavid P, van der Laarse A, Eghbali M. Intralipid prevents and rescues fatal pulmonary arterial hypertension and right ventricular failure in rats. Hypertension 2011: 58(3): 512\u20138.","DOI":"10.1161\/HYPERTENSIONAHA.110.168781"},{"issue":"1","key":"3172_CR36","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00003246-199101000-00016","volume":"19","author":"RC Prielipp","year":"1991","unstructured":"Prielipp RC, McLean R, Rosenthal MH, Pearl RG. Hemodynamic profiles of prostaglandin E1, isoproterenol, Prostacyclin, and Nifedipine in experimental Porcine pulmonary hypertension. Crit Care Med. 1991;19(1):60\u20137.","journal-title":"Crit Care Med"},{"issue":"3","key":"3172_CR37","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1213\/00000539-199709000-00006","volume":"85","author":"F Kunimoto","year":"1997","unstructured":"Kunimoto F, Arai K, Isa Y, Koyano T, Kadoi Y, Saito S, Goto F. A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome. Anesth Analg. 1997;85(3):507\u201313.","journal-title":"Anesth Analg"},{"key":"3172_CR38","doi-asserted-by":"crossref","unstructured":"Radovancevic B, Vrtovec B, Thomas CD, Croitoru M, Myers TJ, Radovancevic R, Khan T, Massin EK, Frazier OH. Nitric oxide versus prostaglandin E1 for reduction of pulmonary hypertension in heart transplant candidates. J Heart Lung Transpl 2005: 24(6): 690\u20135.","DOI":"10.1016\/j.healun.2004.04.016"},{"issue":"2","key":"3172_CR39","doi-asserted-by":"publisher","first-page":"F186","DOI":"10.1136\/archdischild-2012-303294","volume":"98","author":"N Gupta","year":"2013","unstructured":"Gupta N, Kamlin CO, Cheung M, Stewart M, Patel N. Prostaglandin E1 use during neonatal transfer: potential beneficial role in persistent pulmonary hypertension of the newborn. Arch Dis Child Fetal Neonatal Ed. 2013;98(2):F186\u2013188.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"3172_CR40","first-page":"13","volume":"18","author":"CY Zhang","year":"2013","unstructured":"Zhang CY, Ma ZS, Ma LL, Wang LX. Effect of prostaglandin E1 inhalation on pulmonary hypertension following corrective surgery for congenital heart disease. Exp Clin Cardiol. 2013;18(1):13\u20136.","journal-title":"Exp Clin Cardiol"},{"issue":"3","key":"3172_CR41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1161\/01.RES.61.3.420","volume":"61","author":"MH Gee","year":"1987","unstructured":"Gee MH, Tahamont MV, Flynn JT, Cox JW, Pullen RH, Andreadis NA. Prostaglandin E1 prevents increased lung microvascular permeability during intravascular complement activation in sheep. Circ Res. 1987;61(3):420\u20138.","journal-title":"Circ Res"},{"issue":"1","key":"3172_CR42","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jpedsurg.2018.10.039","volume":"54","author":"KM Lawrence","year":"2019","unstructured":"Lawrence KM, Berger K, Herkert L, Franciscovich C, O\u2019Dea CLH, Waqar LN, Partridge E, Hanna BD, Peranteau WH, Avitabile CM, Hopper RK, Rintoul NE, Hedrick HL. Use of prostaglandin E1 to treat pulmonary hypertension in congenital diaphragmatic hernia. J Pediatr Surg. 2019;54(1):55\u20139.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"3172_CR43","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1021\/mp300426u","volume":"10","author":"V Gupta","year":"2013","unstructured":"Gupta V, Gupta N, Shaik IH, Mehvar R, Nozik-Grayck E, McMurtry IF, Oka M, Komatsu M, Ahsan F. Inhaled PLGA particles of prostaglandin E(1) ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency. Mol Pharm. 2013;10(5):1655\u201367.","journal-title":"Mol Pharm"},{"issue":"1","key":"3172_CR44","doi-asserted-by":"publisher","first-page":"11383","DOI":"10.1038\/s41598-018-28951-4","volume":"8","author":"YJ Lai","year":"2018","unstructured":"Lai YJ, Hsu HH, Chang GJ, Lin SH, Chen WJ, Huang CC, Pang JS. Author correction: prostaglandin E1 attenuates pulmonary artery remodeling by activating phosphorylation of CREB and the PTEN signaling pathway. Sci Rep. 2018;8(1):11383.","journal-title":"Sci Rep"},{"issue":"1","key":"3172_CR45","doi-asserted-by":"publisher","first-page":"9974","DOI":"10.1038\/s41598-017-09707-y","volume":"7","author":"Y-J Lai","year":"2017","unstructured":"Lai Y-J, Hsu H-H, Chang G-J, Lin S-H, Chen W-J, Huang C-C, Pang J-HS. Prostaglandin E1 attenuates pulmonary artery remodeling by activating phosphorylation of CREB and the PTEN signaling pathway. Sci Rep. 2017;7(1):9974.","journal-title":"Sci Rep"},{"issue":"1","key":"3172_CR46","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0090-6980(92)90060-7","volume":"43","author":"PJ Pasricha","year":"1992","unstructured":"Pasricha PJ, Hassoun PM, Teufel E, Landman MJ, Fanburg BL. Prostaglandins E1 and E2 stimulate the proliferation of pulmonary artery smooth muscle cells. Prostaglandins. 1992;43(1):5\u201319.","journal-title":"Prostaglandins"},{"issue":"1","key":"3172_CR47","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1080\/17476348.2020.1679628","volume":"14","author":"F Cruz","year":"2020","unstructured":"Cruz F, Rocco P. The potential of mesenchymal stem cell therapy for chronic lung disease. Expert Rev Respir Med. 2020;14(1):31\u20139.","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"3172_CR48","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13287-022-03011-x","volume":"13","author":"D Jiang","year":"2022","unstructured":"Jiang D, Tuo L, Bai X, Bing W, Qu Q, Zhao X, Song G, Bi Y, Sun W. Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha. Stem Cell Res Ther. 2022;13(1):316.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3172_CR49","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0701362","volume":"122","author":"K Nakayama","year":"1997","unstructured":"Nakayama K, Ueta K, Tanaka Y, Tanabe Y, Ishii K. Stretch-induced contraction of rabbit isolated pulmonary artery and the involvement of endothelium-derived thromboxane A2. Br J Pharmacol. 1997;122(2):199\u2013208.","journal-title":"Br J Pharmacol"},{"issue":"21","key":"3172_CR50","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1016\/j.febslet.2013.09.011","volume":"587","author":"K Dey","year":"2013","unstructured":"Dey K, Rahaman SM, Chakraborti T, Chakraborti S. Role of phospholemman and the 70\u00a0kda inhibitor protein in regulating Na+\/K\u2009+\u2009ATPase activity in pulmonary artery smooth muscle cells under U46619 stimulation. FEBS Lett. 2013;587(21):3535\u201340.","journal-title":"FEBS Lett"},{"issue":"1","key":"3172_CR51","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/sj.bjp.0701351","volume":"122","author":"J Tamaoki","year":"1997","unstructured":"Tamaoki J, Tagaya E, Nishimura K, Isono K, Nagai A. Role of Na(+)-K\u2009+\u2009ATPase in Cyclic GMP-mediated relaxation of canine pulmonary artery smooth muscle cells. Br J Pharmacol. 1997;122(1):112\u20136.","journal-title":"Br J Pharmacol"},{"key":"3172_CR52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1196\/annals.1378.053","volume":"1091","author":"A Cogolludo","year":"2006","unstructured":"Cogolludo A, Frazziano G, Cobeno L, Moreno L, Lodi F, Villamor E, Tamargo J, Perez-Vizcaino F. Role of reactive oxygen species in Kv channel Inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteries. Ann N Y Acad Sci. 2006;1091:41\u201351.","journal-title":"Ann N Y Acad Sci"},{"key":"3172_CR53","doi-asserted-by":"crossref","unstructured":"Cogolludo A, Moreno L, Bosca L, Tamargo J, Perez-Vizcaino F. Thromboxane A2-induced Inhibition of voltage-gated K\u2009+\u2009channels and pulmonary vasoconstriction: role of protein kinase Czeta. 2003; pp. 656\u201363.","DOI":"10.1161\/01.RES.0000095245.97945.FE"},{"key":"3172_CR54","doi-asserted-by":"crossref","unstructured":"Chakraborti S, Roy S, Mandal A, Dey K, Chowdhury A, Shaikh S, Chakraborti T. Role of PKCalpha-p(38)MAPK-G(i)alpha axis in NADPH oxidase derived O(2)(.-)-mediated activation of cPLA(2) under U46619 stimulation in pulmonary artery smooth muscle cells. Arch Biochem Biophys 2012: 523(2): 169\u201380.","DOI":"10.1016\/j.abb.2012.04.017"},{"issue":"1","key":"3172_CR55","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cardiores.2004.12.019","volume":"66","author":"A Cogolludo","year":"2005","unstructured":"Cogolludo A, Moreno L, Lodi F, Tamargo J, Perez-Vizcaino F. Postnatal maturational shift from PKCzeta and voltage-gated K\u2009+\u2009channels to RhoA\/Rho kinase in pulmonary vasoconstriction. Cardiovasc Res. 2005;66(1):84\u201393.","journal-title":"Cardiovasc Res"},{"issue":"4","key":"3172_CR56","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00424-015-1778-1","volume":"468","author":"HJ Kim","year":"2016","unstructured":"Kim HJ, Yoo HY, Jang JH, Lin HY, Seo EY, Zhang YH, Kim SJ. Wall stretch and thromboxane A(2) activate NO synthase (eNOS) in pulmonary arterial smooth muscle cells via H(2)O(2) and Akt-dependent phosphorylation. Pflugers Arch. 2016;468(4):705\u201316.","journal-title":"Pflugers Arch"},{"issue":"1\u20132","key":"3172_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11010-013-1814-4","volume":"385","author":"A Chowdhury","year":"2014","unstructured":"Chowdhury A, Roy S, Chakraborti T, Dey K, Chakraborti S. Activation of proMMP-2 by U46619 occurs via involvement of p(38)MAPK-NFkappaB-MT1MMP signaling pathway in pulmonary artery smooth muscle cells. Mol Cell Biochem. 2014;385(1\u20132):53\u201368.","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"3172_CR58","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1002\/cbf.3136","volume":"33","author":"A Chowdhury","year":"2015","unstructured":"Chowdhury A, Sarkar J, Chakraborti T, Chakraborti S. Role of Spm-Cer-S1P signalling pathway in MMP-2 mediated U46619-induced proliferation of pulmonary artery smooth muscle cells: protective role of epigallocatechin-3-gallate. Cell Biochem Funct. 2015;33(7):463\u201377.","journal-title":"Cell Biochem Funct"},{"key":"3172_CR59","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.freeradbiomed.2017.06.022","volume":"110","author":"CE MacKay","year":"2017","unstructured":"MacKay CE, Shaifta Y, Snetkov VV, Francois AA, Ward JPT, Knock GA. ROS-dependent activation of RhoA\/Rho-kinase in pulmonary artery: role of Src-family kinases and ARHGEF1. Free Radic Biol Med. 2017;110:316\u201331.","journal-title":"Free Radic Biol Med"},{"key":"3172_CR60","doi-asserted-by":"crossref","unstructured":"Freitas CF, Faro R, Dragosavac D, Clozel M, De Nucci G, Antunes E. Role of endothelin-1 and thromboxane A2 in the pulmonary hypertension induced by heparin-protamine interaction in anesthetized dogs. 2004; pp. 106\u201312.","DOI":"10.1097\/00005344-200401000-00016"},{"issue":"4","key":"3172_CR61","first-page":"237","volume":"3","author":"H Schweer","year":"1990","unstructured":"Schweer H, Seyberth HW, Kuhl PG, Meese CO. Unusual metabolism of Prostacyclin in infants with persistent septic pulmonary hypertension. Eicosanoids. 1990;3(4):237\u201342.","journal-title":"Eicosanoids"},{"key":"3172_CR62","doi-asserted-by":"publisher","first-page":"640374","DOI":"10.3389\/fphys.2021.640374","volume":"12","author":"BR Lee","year":"2021","unstructured":"Lee BR, Paing MH, Sharma-Walia N. Cyclopentenone prostaglandins: biologically active lipid mediators targeting inflammation. Front Physiol. 2021;12:640374.","journal-title":"Front Physiol"},{"issue":"1","key":"3172_CR63","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1172\/JCI109266","volume":"63","author":"RE Bowers","year":"1979","unstructured":"Bowers RE, Ellis EF, Brigham KL, Oates JA. Effects of prostaglandin Cyclic endoperoxides on the lung circulation of unanesthetized sheep. J Clin Invest. 1979;63(1):131\u20137.","journal-title":"J Clin Invest"},{"issue":"6","key":"3172_CR64","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1203\/00006450-198606000-00019","volume":"20","author":"ML Tod","year":"1986","unstructured":"Tod ML, Cassin S, McNamara DB, Kadowitz PJ. Effects of prostaglandin H2 on perinatal pulmonary circulation. Pediatr Res. 1986;20(6):565\u20139.","journal-title":"Pediatr Res"},{"key":"3172_CR65","doi-asserted-by":"crossref","unstructured":"Konya V, Ullen A, Kampitsch N, Theiler A, Philipose S, Parzmair GP, Marsche G, Peskar BA, Schuligoi R, Sattler W, Heinemann A. Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking. J Allergy Clin Immunol 2013: 131(2): 532\u2013e540531.","DOI":"10.1016\/j.jaci.2012.05.008"},{"issue":"2","key":"3172_CR66","first-page":"273","volume":"33","author":"H Li","year":"1997","unstructured":"Li H, He J, Lee S, Quan C, Ding J. The study of the relationship between the activity of phospholipase A2 and acute hypoxic pulmonary arterial pressure. Ann Ist Super Sanita. 1997;33(2):273\u20137.","journal-title":"Ann Ist Super Sanita"},{"issue":"50","key":"3172_CR67","doi-asserted-by":"publisher","first-page":"49954","DOI":"10.1074\/jbc.M307964200","volume":"278","author":"DA Bradbury","year":"2003","unstructured":"Bradbury DA, Newton R, Zhu YM, El-Haroun H, Corbett L, Knox AJ. Cyclooxygenase-2 induction by Bradykinin in human pulmonary artery smooth muscle cells is mediated by the Cyclic AMP response element through a novel autocrine loop involving endogenous prostaglandin E2, E-prostanoid 2 (EP2), and EP4 receptors. J Biol Chem. 2003;278(50):49954\u201364.","journal-title":"J Biol Chem"},{"issue":"3","key":"3172_CR68","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1161\/01.RES.0000111801.48626.F4","volume":"94","author":"H El-Haroun","year":"2004","unstructured":"El-Haroun H, Bradbury D, Clayton A, Knox AJ. Interleukin-1beta, transforming growth factor-beta1, and Bradykinin attenuate Cyclic AMP production by human pulmonary artery smooth muscle cells in response to Prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation of adenylyl cyclase isoforms 1, 2, and 4. Circ Res. 2004;94(3):353\u201361.","journal-title":"Circ Res"},{"issue":"6","key":"3172_CR69","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1152\/jappl.1988.64.6.2568","volume":"64","author":"KL Brigham","year":"1988","unstructured":"Brigham KL, Serafin W, Zadoff A, Blair I, Meyrick B, Oates JA. Prostaglandin E2 Attenuation of sheep lung responses to endotoxin. J Appl Physiol (1985). 1988;64(6):2568\u201374.","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"3172_CR70","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/jcp.1041380122","volume":"138","author":"B Meyrick","year":"1989","unstructured":"Meyrick B, Hoover R, Jones MR, Berry LC Jr., Brigham KL. In vitro effects of endotoxin on bovine and sheep lung microvascular and pulmonary artery endothelial cells. J Cell Physiol. 1989;138(1):165\u201374.","journal-title":"J Cell Physiol"},{"issue":"2 Pt 1","key":"3172_CR71","first-page":"L239","volume":"268","author":"B Meyrick","year":"1995","unstructured":"Meyrick B, Berry LC Jr., Christman BW. Response of cultured human pulmonary artery endothelial cells to endotoxin. Am J Physiol. 1995;268(2 Pt 1):L239\u2013244.","journal-title":"Am J Physiol"},{"issue":"1","key":"3172_CR72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1161\/01.RES.75.1.33","volume":"75","author":"AJ North","year":"1994","unstructured":"North AJ, Brannon TS, Wells LB, Campbell WB, Shaul PW. Hypoxia stimulates Prostacyclin synthesis in newborn pulmonary artery endothelium by increasing cyclooxygenase-1 protein. Circ Res. 1994;75(1):33\u201340.","journal-title":"Circ Res"},{"issue":"6","key":"3172_CR73","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1165\/ajrcmb\/1.6.489","volume":"1","author":"DB Badesch","year":"1989","unstructured":"Badesch DB, Orton EC, Zapp LM, Westcott JY, Hester J, Voelkel NF, Stenmark KR. Decreased arterial wall prostaglandin production in neonatal calves with severe chronic pulmonary hypertension. Am J Respir Cell Mol Biol. 1989;1(6):489\u201398.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1\u20133","key":"3172_CR74","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0014-5793(04)00064-X","volume":"560","author":"DA Bradbury","year":"2004","unstructured":"Bradbury DA, Corbett L, Knox AJ. PI 3-kinase and MAP kinase regulate Bradykinin induced prostaglandin E(2) release in human pulmonary artery by modulating COX-2 activity. FEBS Lett. 2004;560(1\u20133):30\u20134.","journal-title":"FEBS Lett"},{"issue":"1","key":"3172_CR75","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","volume":"6","author":"B Wang","year":"2021","unstructured":"Wang B, Wu L, Chen J, Dong L, Chen C, Wen Z, Hu J, Fleming I, Wang DW. Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets. Signal Transduct Target Ther. 2021;6(1):94.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"3172_CR76","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1038\/bjp.2008.214","volume":"154","author":"N Foudi","year":"2008","unstructured":"Foudi N, Kotelevets L, Louedec L, Leseche G, Henin D, Chastre E, Norel X. Vasorelaxation induced by prostaglandin E2 in human pulmonary vein: role of the EP4 receptor subtype. Br J Pharmacol. 2008;154(8):1631\u20139.","journal-title":"Br J Pharmacol"},{"key":"3172_CR77","doi-asserted-by":"crossref","unstructured":"Ozen G, Benyahia C, Mani S, Boukais K, Silverstein AM, Bayles R, Nelsen AC, Castier Y, Danel C, Mal H, Clapp LH, Longrois D, Norel X. Bronchodilation induced by PGE is impaired in Group III pulmonary hypertension. 2020; pp. 161\u2013174.","DOI":"10.1111\/bph.14854"},{"issue":"5","key":"3172_CR78","doi-asserted-by":"publisher","first-page":"L810","DOI":"10.1152\/ajplung.00403.2018","volume":"316","author":"S Mukherjee","year":"2019","unstructured":"Mukherjee S, Sheng W, Michkov A, Sriarm K, Sun R, Dvorkin-Gheva A, Insel PA, Janssen LJ. Prostaglandin E2 inhibits profibrotic function of human pulmonary fibroblasts by disrupting Ca(2+) signaling. Am J Physiol Lung Cell Mol Physiol. 2019;316(5):L810\u201321.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"3172_CR79","doi-asserted-by":"crossref","unstructured":"Bozyk PD, Moore BB. Prostaglandin E2 and the pathogenesis of pulmonary fibrosis. Am J Respir Cell Mol Biol 2011: 45(3): 445\u201352.","DOI":"10.1165\/rcmb.2011-0025RT"},{"issue":"5","key":"3172_CR80","doi-asserted-by":"publisher","first-page":"L1257","DOI":"10.1152\/ajplung.2001.281.5.L1257","volume":"281","author":"T Kohyama","year":"2001","unstructured":"Kohyama T, Ertl RF, Valenti V, Spurzem J, Kawamoto M, Nakamura Y, Veys T, Allegra L, Romberger D, Rennard SI. Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol. 2001;281(5):L1257\u201363.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"3172_CR81","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/j.1476-5381.1983.tb08816.x","volume":"78","author":"SJ Coker","year":"1983","unstructured":"Coker SJ, Hughes B, Parratt JR, Rodger IW, Zeitlin IJ. The release of prostanoids during the acute pulmonary response to E. coli endotoxin in anaesthetized cats. Br J Pharmacol. 1983;78(3):561\u201370.","journal-title":"Br J Pharmacol"},{"issue":"4","key":"3172_CR82","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1203\/00006450-199910000-00009","volume":"46","author":"T Matsushita","year":"1999","unstructured":"Matsushita T, Hislop AA, Boels PJ, Deutsch J, Haworth SG. Changes in ANP responsiveness of normal and hypertensive Porcine intrapulmonary arteries during maturation. Pediatr Res. 1999;46(4):411\u20138.","journal-title":"Pediatr Res"},{"issue":"Pt 1","key":"3172_CR83","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1113\/jphysiol.2005.101394","volume":"571","author":"VA Snetkov","year":"2006","unstructured":"Snetkov VA, Knock GA, Baxter L, Thomas GD, Ward JP, Aaronson PI. Mechanisms of the prostaglandin F2alpha-induced rise in [Ca2+]i in rat intrapulmonary arteries. J Physiol. 2006;571(Pt 1):147\u201363.","journal-title":"J Physiol"},{"issue":"1","key":"3172_CR84","first-page":"93","volume":"135","author":"NC Olson","year":"1987","unstructured":"Olson NC. Role of 5-hydroxytryptamine in endotoxin-induced respiratory failure of pigs. Am Rev Respir Dis. 1987;135(1):93\u20139.","journal-title":"Am Rev Respir Dis"},{"issue":"2","key":"3172_CR85","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.cardiores.2004.10.038","volume":"65","author":"M Vankova","year":"2005","unstructured":"Vankova M, Snetkov VA, Knock GA, Aaronson PI, Ward JP. Euhydric hypercapnia increases vasoreactivity of rat pulmonary arteries via HCO3- transport and depolarisation. Cardiovasc Res. 2005;65(2):505\u201312.","journal-title":"Cardiovasc Res"},{"issue":"2","key":"3172_CR86","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1161\/HYPERTENSIONAHA.107.104802","volume":"51","author":"VA Snetkov","year":"2008","unstructured":"Snetkov VA, Thomas GD, Teague B, Leach RM, Shaifta Y, Knock GA, Aaronson PI, Ward JP. Low concentrations of sphingosylphosphorylcholine enhance pulmonary artery vasoreactivity: the role of protein kinase C delta and Ca2\u2009+\u2009entry. Hypertension. 2008;51(2):239\u201345.","journal-title":"Hypertension"},{"issue":"3","key":"3172_CR87","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/cvr\/cvm073","volume":"77","author":"GA Knock","year":"2008","unstructured":"Knock GA, Shaifta Y, Snetkov VA, Vowles B, Drndarski S, Ward JP, Aaronson PI. Interaction between Src family kinases and rho-kinase in agonist-induced Ca2+-sensitization of rat pulmonary artery. Cardiovasc Res. 2008;77(3):570\u20139.","journal-title":"Cardiovasc Res"},{"issue":"3","key":"3172_CR88","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/sj.bjp.0705626","volume":"141","author":"S Muzaffar","year":"2004","unstructured":"Muzaffar S, Shukla N, Lobo C, Angelini GD, Jeremy JY. Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2alpha, prostaglandin F2alpha, cytokines and endotoxin in the pig pulmonary artery. Br J Pharmacol. 2004;141(3):488\u201396.","journal-title":"Br J Pharmacol"},{"issue":"2","key":"3172_CR89","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.pharmthera.2004.01.003","volume":"102","author":"H Olschewski","year":"2004","unstructured":"Olschewski H, Rose F, Schermuly R, Ghofrani HA, Enke B, Olschewski A, Seeger W. Prostacyclin and its analogues in the treatment of pulmonary hypertension. Pharmacol Ther. 2004;102(2):139\u201353.","journal-title":"Pharmacol Ther"},{"key":"3172_CR90","doi-asserted-by":"crossref","unstructured":"O\u2019Connell C, Amar D, Boucly A, Savale L, Ja\u00efs X, Chaumais M-C, Montani D, Humbert M, Simonneau G, Sitbon O. Comparative safety and tolerability of Prostacyclins in pulmonary hypertension. 2016; pp. 287\u201394.","DOI":"10.1007\/s40264-015-0365-x"},{"key":"3172_CR91","doi-asserted-by":"crossref","unstructured":"Tamosiuniene R, Manouvakhova O, Mesange P, Saito T, Qian J, Sanyal M, Lin Y-C, Nguyen LP, Luria A, Tu AB, Sante JM, Rabinovitch M, Fitzgerald DJ, Graham BB, Habtezion A, Voelkel NF, Aurelian L, Nicolls MR. Dominant role for regulatory T cells in protecting females against pulmonary hypertension. 2018; pp. 1689\u2013702.","DOI":"10.1161\/CIRCRESAHA.117.312058"},{"issue":"3","key":"3172_CR92","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijcard.2011.09.004","volume":"165","author":"S Akagi","year":"2013","unstructured":"Akagi S, Nakamura K, Matsubara H, Kusano KF, Kataoka N, Oto T, Miyaji K, Miura A, Ogawa A, Yoshida M, Ueda-Ishibashi H, Yutani C, Ito H. Prostaglandin I2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. Int J Cardiol. 2013;165(3):499\u2013505.","journal-title":"Int J Cardiol"},{"issue":"6","key":"3172_CR93","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1067\/mpd.2002.129849","volume":"141","author":"LK Kelly","year":"2002","unstructured":"Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinhorn RH. Inhaled Prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr. 2002;141(6):830\u20132.","journal-title":"J Pediatr"},{"key":"3172_CR94","doi-asserted-by":"crossref","unstructured":"Gatfield J, Menyhart K, Wanner D, Gnerre C, Monnier L, Morrison K, Hess P, Iglarz M, Clozel M, Nayler O. Selexipag Active Metabolite ACT-333679 Displays Strong Anticontractile and Antiremodeling Effects but Low -Arrestin Recruitment and Desensitization Potential. 2017; pp. 186\u2013199.","DOI":"10.1124\/jpet.116.239665"},{"key":"3172_CR95","doi-asserted-by":"crossref","unstructured":"Fedorowicz A, Mateuszuk \u0141, Kopec G, Sk\u00f3rka T, Kutryb-Zaj\u0105c B, Zakrzewska A, Walczak M, Jakubowski A, \u0141omnicka M, S\u0142omi\u0144ska E, Chlopicki S. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension. 2016; p. 108.","DOI":"10.1186\/s12931-016-0423-7"},{"key":"3172_CR96","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.plipres.2017.04.003","volume":"66","author":"M-J Seo","year":"2017","unstructured":"Seo M-J, Oh D-K. Prostaglandin synthases: molecular characterization and involvement in prostaglandin biosynthesis. Prog Lipid Res. 2017;66:50\u201368.","journal-title":"Prog Lipid Res"},{"key":"3172_CR97","doi-asserted-by":"crossref","unstructured":"Jia D, Bai P, Wan N, Liu J, Zhu Q, He Y, Chen G, Wang J, Chen H, Wang C, Lyu A, Lazarus M, Su Y, Urade Y, Yu Y, Zhang J, Shen Y. Niacin Attenuates Pulmonary Hypertension Through H-PGDS in Macrophages. 2020; pp. 1323\u20131336.","DOI":"10.1161\/CIRCRESAHA.120.316784"},{"key":"3172_CR98","doi-asserted-by":"crossref","unstructured":"He Y, Zuo C, Jia D, Bai P, Kong D, Chen D, Liu G, Li J, Wang Y, Chen G, Yan S, Xiao B, Zhang J, Piao L, Li Y, Deng Y, Li B, Roux PP, Andreasson KI, Breyer RM, Su Y, Wang J, Lyu A, Shen Y, Yu Y. Loss of DP1 aggravates vascular remodeling in pulmonary arterial hypertension via mTORC1 signaling. 2020; pp. 1263\u201376.","DOI":"10.1164\/rccm.201911-2137OC"},{"issue":"5","key":"3172_CR99","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1378\/chest.120.5.1639","volume":"120","author":"IM Robbins","year":"2001","unstructured":"Robbins IM, Barst RJ, Rubin LJ, Gaine SP, Price PV, Morrow JD, Christman BW. Increased levels of prostaglandin D(2) suggest macrophage activation in patients with primary pulmonary hypertension. Chest. 2001;120(5):1639\u201344.","journal-title":"Chest"},{"issue":"4","key":"3172_CR100","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1183\/09031936.02.01272001","volume":"19","author":"T Kohyama","year":"2002","unstructured":"Kohyama T, Liu XD, Wen FQ, Kim HJ, Takizawa H, Rennard SI. Prostaglandin D2 inhibits fibroblast migration. Eur Respir J. 2002;19(4):684\u20139.","journal-title":"Eur Respir J"},{"key":"3172_CR101","doi-asserted-by":"crossref","unstructured":"Ayabe S, Kida T, Hori M, Ozaki H, Murata T. Prostaglandin D2 inhibits collagen secretion from lung fibroblasts by activating the DP receptor. J Pharmacol Sci 2013: 121(4): 312\u20137.","DOI":"10.1254\/jphs.12275FP"},{"issue":"4","key":"3172_CR102","doi-asserted-by":"publisher","first-page":"L569","DOI":"10.1152\/ajplung.00565.2016","volume":"314","author":"SH Lacy","year":"2018","unstructured":"Lacy SH, Epa AP, Pollock SJ, Woeller CF, Thatcher TH, Phipps RP, Sime PJ. Activated human T lymphocytes inhibit TGF\u03b2-induced fibroblast to myofibroblast differentiation via prostaglandins D and E. Am J Physiol Lung Cell Mol Physiol. 2018;314(4):L569\u201382.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"3172_CR103","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/S0022-3476(88)80701-7","volume":"112","author":"SJ Soifer","year":"1988","unstructured":"Soifer SJ, Clyman RI, Heymann MA. Effects of prostaglandin D2 on pulmonary arterial pressure and oxygenation in newborn infants with persistent pulmonary hypertension. J Pediatr. 1988;112(5):774\u20137.","journal-title":"J Pediatr"},{"issue":"6","key":"3172_CR104","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1042\/CS20110205","volume":"122","author":"A Mishra","year":"2012","unstructured":"Mishra A, Ali Z, Vibhuti A, Kumar R, Alam P, Ram R, Thinlas T, Mohammad G, Pasha MA. CYBA and GSTP1 variants associate with oxidative stress under hypobaric hypoxia as observed in high-altitude pulmonary oedema. Clin Sci (Lond). 2012;122(6):299\u2013309.","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"3172_CR105","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.plefa.2008.01.006","volume":"78","author":"M Lipcsey","year":"2008","unstructured":"Lipcsey M, Soderberg E, Basu S, Larsson A, Sjolin J, Astrom M, Eriksson MB. F2-isoprostane, inflammation, cardiac function and oxygenation in the endotoxaemic pig. Prostaglandins Leukot Essent Fat Acids. 2008;78(3):209\u201317.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"key":"3172_CR106","doi-asserted-by":"crossref","unstructured":"Jankov RP, Luo X, Cabacungan J, Belcastro R, Frndova H, Lye SJ, Tanswell AK. Endothelin-1 and O2-mediated pulmonary hypertension in neonatal rats: a role for products of lipid peroxidation. 2000; pp. 289\u201398.","DOI":"10.1203\/00006450-200009000-00005"},{"key":"3172_CR107","doi-asserted-by":"crossref","unstructured":"Yi SL, Kantores C, Belcastro R, Cabacungan J, Tanswell AK, Jankov RP. 8-Isoprostane-induced endothelin-1 production by infant rat pulmonary artery smooth muscle cells is mediated by Rho-kinase. pp. 942\u20139.","DOI":"10.1016\/j.freeradbiomed.2006.05.035"},{"issue":"7","key":"3172_CR108","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.freeradbiomed.2010.01.009","volume":"48","author":"Y Gong","year":"2010","unstructured":"Gong Y, Yi M, Fediuk J, Lizotte PP, Dakshinamurti S. Hypoxic neonatal pulmonary arterial myocytes are sensitized to ROS-generated 8-isoprostane. Free Radic Biol Med. 2010;48(7):882\u201394.","journal-title":"Free Radic Biol Med"},{"key":"3172_CR109","doi-asserted-by":"crossref","unstructured":"Belik J, Jankov RP, Pan J, Yi M, Chaudhry I, Tanswell AK. Chronic O2 exposure in the newborn rat results in decreased pulmonary arterial nitric oxide release and altered smooth muscle response to isoprostane. 2004; pp. 725\u201330.","DOI":"10.1152\/japplphysiol.00825.2003"},{"key":"3172_CR110","doi-asserted-by":"crossref","unstructured":"Hart CM, Karman RJ, Blackburn TL, Gupta MP, Garcia JG, Mohler ER. Role of 8-epi PGF2alpha, 8-isoprostane, in H2O2-induced derangements of pulmonary artery endothelial cell barrier function. 1998.","DOI":"10.1016\/S0952-3278(98)90124-7"},{"key":"3172_CR111","doi-asserted-by":"publisher","first-page":"745984","DOI":"10.1155\/2013\/745984","volume":"2013","author":"D Vecchio","year":"2013","unstructured":"Vecchio D, Acquaviva A, Arezzini B, Tenor H, Martorana PA, Gardi C. Downregulation of NOX4 expression by Roflumilast N-oxide reduces markers of fibrosis in lung fibroblasts. Mediators Inflamm. 2013;2013:745984.","journal-title":"Mediators Inflamm"},{"key":"3172_CR112","doi-asserted-by":"crossref","unstructured":"Belik J, Jankov RP, Pan J, Yi M, Pace-Asciak CR, Tanswell AK. Effect of 8-isoprostaglandin F2alpha on the newborn rat pulmonary arterial muscle and endothelium. 2003; pp. 1979\u201385.","DOI":"10.1152\/japplphysiol.00420.2003"},{"key":"3172_CR113","doi-asserted-by":"crossref","unstructured":"Ohmura T, Tian Y, Sarich N, Ke Y, Meliton A, Shah AS, Andreasson K, Birukov KG, Birukova AA. Regulation of lung endothelial permeability and inflammatory responses by prostaglandin A2: role of EP4 receptor. Mol Biol Cell 2017: 28(12): 1622\u201335.","DOI":"10.1091\/mbc.e16-09-0639"},{"issue":"5","key":"3172_CR114","doi-asserted-by":"publisher","first-page":"815","DOI":"10.3760\/cma.j.issn.0366-6999.20131079","volume":"127","author":"D Liu","year":"2014","unstructured":"Liu D, Geng Z, Zhu W, Wang H, Chen Y, Liang J. 15-deoxy-Delta(1)(2),(1)(4)-prostaglandin J(2) ameliorates endotoxin-induced acute lung injury in rats. Chin Med J (Engl). 2014;127(5):815\u201320.","journal-title":"Chin Med J (Engl)"},{"issue":"2","key":"3172_CR115","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1183\/09031936.05.00049704","volume":"25","author":"T Genovese","year":"2005","unstructured":"Genovese T, Cuzzocrea S, Di Paola R, Mazzon E, Mastruzzo C, Catalano P, Sortino M, Crimi N, Caputi AP, Thiemermann C, Vancheri C. Effect of Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. Eur Respir J. 2005;25(2):225\u201334.","journal-title":"Eur Respir J"},{"key":"3172_CR116","doi-asserted-by":"crossref","unstructured":"Ando M, Murakami Y, Kojima F, Endo H, Kitasato H, Hashimoto A, Kobayashi H, Majima M, Inoue M, Kondo H, Kawai S, Hayashi I. Retrovirally introduced prostaglandin D2 synthase suppresses lung injury induced by bleomycin. Am J Respir Cell Mol Biol 2003: 28(5): 582\u201391.","DOI":"10.1165\/rcmb.2002-0162OC"},{"issue":"4","key":"3172_CR117","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1093\/infdis\/jir804","volume":"205","author":"A Cloutier","year":"2012","unstructured":"Cloutier A, Marois I, Cloutier D, Verreault C, Cantin AM, Richter MV. The prostanoid 15-deoxy-Delta12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection. J Infect Dis. 2012;205(4):621\u201330.","journal-title":"J Infect Dis"},{"issue":"1","key":"3172_CR118","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/01.ATV.0000044461.01844.C9","volume":"23","author":"DS Calnek","year":"2003","unstructured":"Calnek DS, Mazzella L, Roser S, Roman J, Hart CM. Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells. Arterioscler Thromb Vasc Biol. 2003;23(1):52\u20137.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"3172_CR119","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/09629359791910","volume":"6","author":"H Ijsselstijn","year":"1997","unstructured":"Ijsselstijn H, Zijlstra FJ, Van Dijk JP, De Jongste JC, Tibboel D. Lung eicosanoids in perinatal rats with congenital diaphragmatic hernia. Mediators Inflamm. 1997;6(1):39\u201345.","journal-title":"Mediators Inflamm"},{"key":"3172_CR120","doi-asserted-by":"crossref","unstructured":"Tian W, Jiang X, Sung YK, Qian J, Yuan K, Nicolls MR. Leukotrienes in pulmonary arterial hypertension. 2014; pp. 387\u2013393.","DOI":"10.1007\/s12026-014-8492-5"},{"key":"3172_CR121","unstructured":"Tabata T, Ono S, Song C, Noda M, Suzuki S, Tanita T, Fujimura S. [Role of leukotriene B4 in monocrotaline-induced pulmonary hypertension]. 1997; pp. 160\u20136."},{"key":"3172_CR122","unstructured":"Tian W, Jiang X, Tamosiuniene R, Sung YK, Qian J, Dhillon G, Gera L, Farkas L, Rabinovitch M, Zamanian RT, Inayathullah M, Fridlib M, Rajadas J, Peters-Golden M, Voelkel NF, Nicolls MR. Blocking macrophage leukotriene b4 prevents endothelial injury and reverses pulmonary hypertension. p. 200ra117."},{"key":"3172_CR123","doi-asserted-by":"crossref","unstructured":"Li F, You Y, Zhu H. 15-HETE protects pulmonary artery smooth muscle cells against apoptosis via SIRT1 regulation during hypoxia. 2018; pp. 325\u201330.","DOI":"10.1016\/j.biopha.2018.07.166"},{"key":"3172_CR124","doi-asserted-by":"crossref","unstructured":"Zhang L, Ma J, Shen T, Wang S, Ma C, Liu Y, Ran Y, Wang L, Liu L, Zhu D. Platelet-derived growth factor (PDGF) induces pulmonary vascular remodeling through 15-LO\/15-HETE pathway under hypoxic condition. 2012; pp. 1931\u20139.","DOI":"10.1016\/j.cellsig.2012.06.007"},{"key":"3172_CR125","doi-asserted-by":"crossref","unstructured":"Yao L, Nie X, Shi S, Song S, Hao X, Li S, Zhu D. Reciprocal regulation of HIF-1\u03b1 and 15-LO\/15-HETE promotes anti-apoptosis process in pulmonary artery smooth muscle cells during hypoxia. 2012.","DOI":"10.1016\/j.prostaglandins.2012.09.001"},{"key":"3172_CR126","doi-asserted-by":"crossref","unstructured":"Ma J, Liang S, Wang Z, Zhang L, Jiang J, Zheng J, Yu L, Zheng X, Wang R, Zhu D. ROCK pathway participates in the processes that 15-hydroxyeicosatetraenoic acid (15-HETE) mediated the pulmonary vascular remodeling induced by hypoxia in rat. 2010; pp. 82\u201394.","DOI":"10.1002\/jcp.21923"},{"issue":"1\u20132","key":"3172_CR127","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.prostaglandins.2009.12.007","volume":"91","author":"S Wang","year":"2010","unstructured":"Wang S, Wang Y, Jiang J, Wang R, Li L, Qiu Z, Wu H, Zhu D. 15-HETE protects rat pulmonary arterial smooth muscle cells from apoptosis via the PI3K\/Akt pathway. Prostaglandins Other Lipid Mediat. 2010;91(1\u20132):51\u201360.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"6","key":"3172_CR128","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1159\/000374015","volume":"35","author":"X Yu","year":"2015","unstructured":"Yu X, Li T, Liu X, Yu H, Hao Z, Chen Y, Zhang C, Liu Y, Li Q, Mao M, Zhu D. Modulation of pulmonary vascular remodeling in hypoxia: role of 15-LOX-2\/15-HETE-MAPKs pathway. Cell Physiol Biochem. 2015;35(6):2079\u201397.","journal-title":"Cell Physiol Biochem"},{"key":"3172_CR129","doi-asserted-by":"crossref","unstructured":"Nie X, Song S, Zhang L, Qiu Z, Shi S, Liu Y, Yao L, Zhu D. 15-Hydroxyeicosatetraenoic acid (15-HETE) protects pulmonary artery smooth muscle cells from apoptosis via inducible nitric oxide synthase (iNOS) pathway. 2012; pp. 50\u201359.","DOI":"10.1016\/j.prostaglandins.2011.11.003"},{"issue":"1","key":"3172_CR130","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s10495-008-0286-6","volume":"14","author":"Y Li","year":"2009","unstructured":"Li Y, Li Q, Wang Z, Liang D, Liang S, Tang X, Guo L, Zhang R, Zhu D. 15-HETE suppresses K(+) channel activity and inhibits apoptosis in pulmonary artery smooth muscle cells. Apoptosis. 2009;14(1):42\u201351.","journal-title":"Apoptosis"},{"key":"3172_CR131","doi-asserted-by":"crossref","unstructured":"Yu X, Wei L, Lu P, Shen T, Liu X, Li T, Zhang B, Yu H, Zhu D. 15-Lipoxygenase promotes chronic hypoxia-induced phenotype changes of PASMCs via positive feedback-loop of BMP4. 2015; pp. 1489\u2013502.","DOI":"10.1002\/jcp.24893"},{"key":"3172_CR132","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12944-015-0174-3","volume":"15","author":"L Zhang","year":"2016","unstructured":"Zhang L, Chen Y, Li G, Chen M, Huang W, Liu Y, Li Y. TGF-\u03b21\/FGF-2 signaling mediates the 15-HETE-induced differentiation of adventitial fibroblasts into myofibroblasts. Lipids Health Dis. 2016;15:2.","journal-title":"Lipids Health Dis"},{"key":"3172_CR133","doi-asserted-by":"crossref","unstructured":"Zhang L, Li Y, Chen M, Su X, Yi D, Lu P, Zhu D. 15-LO\/15-HETE mediated vascular adventitia fibrosis via p38 MAPK-dependent TGF-\u03b2. 2014; pp. 245\u201357.","DOI":"10.1002\/jcp.24443"},{"key":"3172_CR134","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jsbmb.2015.01.015","volume":"149","author":"L Zhang","year":"2015","unstructured":"Zhang L, Li Y, Liu Y, Wang X, Chen M, Xing Y, Zhu D. STAT3-mediated MMP-2 expression is required for 15-HETE-induced vascular adventitial fibroblast migration. J Steroid Biochem Mol Biol. 2015;149:106\u201317.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3172_CR135","doi-asserted-by":"crossref","unstructured":"Zhang M, Xin W, Ma C, Zhang H, Mao M, Liu Y, Zheng X, Zhang L, Yu X, Li H, Zhu D. Exosomal 15-LO2 mediates hypoxia-induced pulmonary artery hypertension in vivo and in vitro. Cell Death Dis 2018: 9(10): 1022.","DOI":"10.1038\/s41419-018-1073-0"},{"key":"3172_CR136","doi-asserted-by":"crossref","unstructured":"Ma C, Wang Y, Shen T, Zhang C, Ma J, Zhang L, Liu F, Zhu D. Placenta growth factor mediates angiogenesis in hypoxic pulmonary hypertension. 2013; pp. 159\u201368.","DOI":"10.1016\/j.plefa.2013.08.005"},{"key":"3172_CR137","doi-asserted-by":"crossref","unstructured":"Ma C, Li Y, Ma J, Liu Y, Li Q, Niu S, Shen Z, Zhang L, Pan Z, Zhu D. Key role of 15-lipoxygenase\/15-hydroxyeicosatetraenoic acid in pulmonary vascular remodeling and vascular angiogenesis associated with hypoxic pulmonary hypertension. 2011; pp. 679\u201388.","DOI":"10.1161\/HYPERTENSIONAHA.111.171561"},{"key":"3172_CR138","doi-asserted-by":"crossref","unstructured":"Li Q, Mao M, Qiu Y, Liu G, Sheng T, Yu X, Wang S, Zhu D. Key role of ROS in the process of 15-Lipoxygenase\/15-Hydroxyeicosatetraenoiccid-Induced pulmonary vascular remodeling in hypoxia pulmonary hypertension. 2016; p. e0149164.","DOI":"10.1371\/journal.pone.0149164"},{"key":"3172_CR139","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang H, Yan L, Du W, Zhang M, Chen H, Zhang L, Li G, Li J, Dong Y, Zhu D. MMP-2 and MMP-9 contribute to the angiogenic effect produced by hypoxia\/15-HETE in pulmonary endothelial cells. 2018; pp. 36\u201350.","DOI":"10.1016\/j.yjmcc.2018.06.006"},{"key":"3172_CR140","doi-asserted-by":"crossref","unstructured":"Ruffenach G, O\u2019Connor E, Vaillancourt M, Hong J, Cao N, Sarji S, Moazeni S, Papesh J, Grijalva V, Cunningham CM, Shu L, Chattopadhyay A, Tiwari S, Mercier O, Perros F, Umar S, Yang X, Gomes AV, Fogelman AM, Reddy ST, Eghbali M. Oral 15-Hydroxyeicosatetraenoic acid induces pulmonary hypertension in mice by triggering T cell-Dependent endothelial cell apoptosis. 2020; pp. 985\u201396.","DOI":"10.1161\/HYPERTENSIONAHA.120.14697"},{"key":"3172_CR141","doi-asserted-by":"crossref","unstructured":"Li J, Rao J, Liu Y, Cao Y, Zhang Y, Zhang Q, Zhu D. 15-Lipoxygenase promotes chronic hypoxia-induced pulmonary artery inflammation via positive interaction with nuclear factor-\u03baB. 2013; pp. 971\u20139.","DOI":"10.1161\/ATVBAHA.113.301335"},{"issue":"3","key":"3172_CR142","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/S0022-3565(25)09596-5","volume":"273","author":"H Matsuda","year":"1995","unstructured":"Matsuda H, Miyatake K, Dahl\u00e9n SE. Pharmacodynamics of 15(S)-hydroperoxyeicosatetraenoic (15-HPETE) and 15(S)-hydroxyeicosatetraenoic acid (15-HETE) in isolated arteries from guinea pig, rabbit, rat and human. J Pharmacol Exp Ther. 1995;273(3):1182\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"3172_CR143","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0952-3278(96)90071-X","volume":"54","author":"MJ Van Diest","year":"1996","unstructured":"Van Diest MJ, Herman AG, Verbeuren TJ. Influence of hypercholesterolaemia on the reactivity of isolated rabbit arteries to 15-lipoxygenase metabolites of arachidonic acid: comparison with platelet-derived agents and vasodilators. Prostaglandins Leukot Essent Fat Acids. 1996;54(2):135\u201345.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"3\u20134","key":"3172_CR144","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.prostaglandins.2010.06.008","volume":"93","author":"X Li","year":"2010","unstructured":"Li X, Ma C, Zhu D, Meng L, Guo L, Wang Y, Zhang L, Li Z, Li E. Increased expression and altered subcellular distribution of PKC-\u03b4 and PKC-\u025b in pulmonary arteries exposed to hypoxia and 15-HETE. Prostaglandins Other Lipid Mediat. 2010;93(3\u20134):84\u201392.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"10","key":"3172_CR145","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1139\/y06-057","volume":"84","author":"C Lu","year":"2006","unstructured":"Lu C, Liu Y, Tang X, Ye H, Zhu D. Role of 15-hydroxyeicosatetraenoic acid in phosphorylation of ERK1\/2 and Caldesmon in pulmonary arterial smooth muscle cells. Can J Physiol Pharmacol. 2006;84(10):1061\u20139.","journal-title":"Can J Physiol Pharmacol"},{"issue":"1\u20133","key":"3172_CR146","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejphar.2008.10.028","volume":"601","author":"X Zheng","year":"2008","unstructured":"Zheng X, Li Q, Tang X, Liang S, Chen L, Zhang S, Wang Z, Guo L, Zhang R, Zhu D. Source of the elevation Ca2\u2009+\u2009evoked by 15-HETE in pulmonary arterial myocytes. Eur J Pharmacol. 2008;601(1\u20133):16\u201322.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"3172_CR147","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/jb\/mvq010","volume":"147","author":"Y Wang","year":"2010","unstructured":"Wang Y, Liang D, Wang S, Qiu Z, Chu X, Chen S, Li L, Nie X, Zhang R, Wang Z, Zhu D. Role of the G-protein and tyrosine kinase\u2013Rho\/ROK pathways in 15-hydroxyeicosatetraenoic acid induced pulmonary vasoconstriction in hypoxic rats. J Biochem. 2010;147(5):751\u201364.","journal-title":"J Biochem"},{"key":"3172_CR148","doi-asserted-by":"crossref","unstructured":"Bergholte JM, Soberman RJ, Hayes R, Murphy RC, Okita RT. Oxidation of 15-hydroxyeicosatetraenoic acid and other hydroxy fatty acids by lung prostaglandin dehydrogenase. Arch Biochem Biophys 1987: 257(2): 444\u201350.","DOI":"10.1016\/0003-9861(87)90589-3"},{"key":"3172_CR149","doi-asserted-by":"crossref","unstructured":"Ma C, Liu Y, Wang Y, Zhang C, Yao H, Ma J, Zhang L, Zhang D, Shen T, Zhu D. Hypoxia activates 15-PGDH and its metabolite 15-KETE to promote pulmonary artery endothelial cells proliferation via ERK1\/2 signalling. 2014; pp. 3352\u201363.","DOI":"10.1111\/bph.12594"},{"key":"3172_CR150","doi-asserted-by":"crossref","unstructured":"Wei L, Yu X, Shi H, Zhang B, Lian M, Li J, Shen T, Xing Y, Zhu D. 15-PGDH\/15-KETE plays a role in hypoxia-induced pulmonary vascular remodeling through ERK1\/2-dependent PAR-2 pathway. 2014; pp. 1476\u201388.","DOI":"10.1016\/j.cellsig.2014.03.008"},{"key":"3172_CR151","doi-asserted-by":"crossref","unstructured":"Sugumaran PK, Wang S, Song S, Nie X, Zhang L, Feng Y, Ma W, Zhu D. 15-oxo-Eicosatetraenoic acid prevents serum deprivation-induced apoptosis of pulmonary arterial smooth muscle cells by activating pro-survival pathway. 2014; pp. 89\u201398.","DOI":"10.1016\/j.plefa.2014.01.006"},{"key":"3172_CR152","doi-asserted-by":"crossref","unstructured":"Zhang C, Ma C, Yao H, Zhang L, Yu X, Liu Y, Shen T, Zhang L, Zhang F, Chen X, Zhu D. 12-Lipoxygenase and 12-hydroxyeicosatetraenoic acid regulate hypoxic angiogenesis and survival of pulmonary artery endothelial cells via PI3K\/Akt pathway. 2018; pp. L606\u201316.","DOI":"10.1152\/ajplung.00049.2017"},{"key":"3172_CR153","doi-asserted-by":"crossref","unstructured":"Preston IR, Hill NS, Warburton RR, Fanburg BL. Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation. 2006; pp. L367\u201374.","DOI":"10.1152\/ajplung.00114.2005"},{"key":"3172_CR154","doi-asserted-by":"crossref","unstructured":"Burhop KE, Selig WM, Malik AB. Monohydroxyeicosatetraenoic acids (5-HETE and 15-HETE) induce pulmonary vasoconstriction and edema. 1988; pp. 687\u2013698.","DOI":"10.1161\/01.RES.62.4.687"},{"issue":"5","key":"3172_CR155","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12576-010-0105-z","volume":"60","author":"L Guo","year":"2010","unstructured":"Guo L, Qiu Z, Zhang L, Chen S, Zhu D. Hypoxia suppresses Kv 2.1 channel expression through endogenous 15-hydroxyeicosatetraenoic acid in rat pulmonary artery. J Physiol Sci. 2010;60(5):373\u201381.","journal-title":"J Physiol Sci"},{"key":"3172_CR156","doi-asserted-by":"crossref","unstructured":"Voelkel NF, Tuder RM, Wade K, H\u00f6per M, Lepley RA, Goulet JL, Koller BH, Fitzpatrick F. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. 1996; pp. 2491\u20138.","DOI":"10.1172\/JCI118696"},{"key":"3172_CR157","doi-asserted-by":"crossref","unstructured":"Walker JL, Loscalzo J, Zhang Y-Y. 5-Lipoxygenase and human pulmonary artery endothelial cell proliferation. 2002; pp. H585\u201393.","DOI":"10.1152\/ajpheart.00003.2001"},{"key":"3172_CR158","doi-asserted-by":"crossref","unstructured":"Ma J, Zhang L, Han W, Shen T, Ma C, Liu Y, Nie X, Liu M, Ran Y, Zhu D. Activation of JNK\/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells. 2012; pp. 1093\u2013105.","DOI":"10.1194\/jlr.M024398"},{"key":"3172_CR159","doi-asserted-by":"crossref","unstructured":"Keser\u00fc B, Barbosa-Sicard E, Schermuly RT, Tanaka H, Hammock BD, Weissmann N, Fisslthaler B, Fleming I. Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. Inhibition. 2010; pp. 232\u201340.","DOI":"10.1093\/cvr\/cvp281"},{"key":"3172_CR160","doi-asserted-by":"crossref","unstructured":"Revermann M, Barbosa-Sicard E, Dony E, Schermuly RT, Morisseau C, Geisslinger G, Fleming I, Hammock BD, Brandes RP. Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats. 2009; pp. 322\u201331.","DOI":"10.1097\/HJH.0b013e32831aedfa"},{"key":"3172_CR161","doi-asserted-by":"crossref","unstructured":"Wepler M, Beloiartsev A, Buswell MD, Panigrahy D, Malhotra R, Buys ES, Radermacher P, Ichinose F, Bloch DB, Zapol WM. Soluble epoxide hydrolase deficiency or Inhibition enhances murine hypoxic pulmonary vasoconstriction after lipopolysaccharide challenge. 2016; pp. L1213\u201321.","DOI":"10.1152\/ajplung.00394.2016"},{"key":"3172_CR162","doi-asserted-by":"crossref","unstructured":"Pokreisz P, Fleming I, Kiss L, Barbosa-Sicard E, Fisslthaler B, Falck JR, Hammock BD, Kim I-H, Szelid Z, Vermeersch P, Gillijns H, Pellens M, Grimminger F, van Zonneveld A-J, Collen D, Busse R, Janssens S. Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling. 2006; pp. 762\u201370.","DOI":"10.1161\/01.HYP.0000208299.62535.58"},{"key":"3172_CR163","doi-asserted-by":"crossref","unstructured":"Kandhi S, Alruwaili N, Wolin MS, Sun D, Huang A. Reciprocal actions of constrictor prostanoids and superoxide in chronic hypoxia-induced pulmonary hypertension: roles of EETs. 2019; p. 2045894019895947.","DOI":"10.1177\/2045894019895947"},{"key":"3172_CR164","doi-asserted-by":"crossref","unstructured":"Beloiartsev A, Da Gl\u00f3ria Rodrigues-Machado M, Zhou GL, Tan TC, Zazzeron L, Tainsh RE, Leyton P, Jones RC, Scherrer-Crosbie M, Zapol WM. Pulmonary hypertension after prolonged hypoxic exposure in mice with a congenital deficiency of Cyp2j. 2015; pp. 563\u201370.","DOI":"10.1165\/rcmb.2013-0482OC"},{"key":"3172_CR165","doi-asserted-by":"crossref","unstructured":"Joshi SR, Lakhkar A, Dhagia V, Zias AL, Soldatos V, Oshima K, Jiang H, Gotlinger K, Capdevila JH, Schwartzman ML, McMurtry IF, Gupte SA. Cyp2c44 gene disruption exacerbated pulmonary hypertension and heart failure in female but not male mice. 2016; pp. 360\u20138.","DOI":"10.1086\/688060"},{"key":"3172_CR166","doi-asserted-by":"crossref","unstructured":"Feng W, Xu X, Zhao G, Li G, Liu T, Zhao J, Dong R, Wang DW, Tu L. EETs and CYP2J2 inhibit TNF-\u03b1-induced apoptosis in pulmonary artery endothelial cells and TGF-\u03b21-induced migration in pulmonary artery smooth muscle cells. 2013; pp. 685\u201393.","DOI":"10.3892\/ijmm.2013.1435"},{"key":"3172_CR167","doi-asserted-by":"crossref","unstructured":"Zheng C, Wang L, Li R, Ma B, Tu L, Xu X, Dackor RT, Zeldin DC, Wang DW. Gene delivery of cytochrome p450 epoxygenase ameliorates monocrotaline-induced pulmonary artery hypertension in rats. 2010; pp. 740\u20139.","DOI":"10.1165\/rcmb.2009-0161OC"},{"key":"3172_CR168","doi-asserted-by":"crossref","unstructured":"Tan JZ, Kaley G, Gurtner GH. Nitric oxide and prostaglandins mediate vasodilation to 5,6-EET in rabbit lung. 1997; pp. 561\u2013566.","DOI":"10.1007\/978-1-4899-1813-0_85"},{"issue":"1","key":"3172_CR169","doi-asserted-by":"publisher","first-page":"e13521","DOI":"10.1111\/apha.13521","volume":"230","author":"I Strielkov","year":"2020","unstructured":"Strielkov I, Krause NC, Knoepp F, Alebrahimdehkordi N, Pak O, Garcia C, Ghofrani HA, Schermuly RT, Seeger W, Grimminger F, Sommer N, Weissmann N. Cytochrome P450 epoxygenase-derived 5,6-epoxyeicosatrienoic acid relaxes pulmonary arteries in normoxia but promotes sustained pulmonary vasoconstriction in hypoxia. Acta Physiol (Oxf). 2020;230(1):e13521.","journal-title":"Acta Physiol (Oxf)"},{"key":"3172_CR170","doi-asserted-by":"crossref","unstructured":"Moreland KT, Procknow JD, Sprague RS, Iverson JL, Lonigro AJ, Stephenson AH. Cyclooxygenase (COX)-1 and COX-2 participate in 5,6-epoxyeicosatrienoic acid-induced contraction of rabbit intralobar pulmonary arteries. 2007; pp. 446\u201354.","DOI":"10.1124\/jpet.106.107904"},{"key":"3172_CR171","doi-asserted-by":"crossref","unstructured":"Fuloria M, Smith TK, Aschner JL. Role of 5,6-epoxyeicosatrienoic acid in the regulation of newborn piglet pulmonary vascular tone. 2002; pp. L383\u20139.","DOI":"10.1152\/ajplung.00444.2001"},{"key":"3172_CR172","doi-asserted-by":"crossref","unstructured":"Stephenson AH, Sprague RS, Losapio JL, Lonigro AJ. Differential effects of 5,6-EET on segmental pulmonary vasoactivity in the rabbit. 2003; pp. H2153\u201361.","DOI":"10.1152\/ajpheart.00844.2002"},{"key":"3172_CR173","doi-asserted-by":"crossref","unstructured":"Losapio JL, Sprague RS, Lonigro AJ, Stephenson AH. 5,6-EET-induced contraction of intralobar pulmonary arteries depends on the activation of Rho-kinase. 2005; pp. 1391\u20136.","DOI":"10.1152\/japplphysiol.00473.2005"},{"key":"3172_CR174","doi-asserted-by":"crossref","unstructured":"Zhu D, Bousamra M, Zeldin DC, Falck JR, Townsley M, Harder DR, Roman RJ, Jacobs ER. Epoxyeicosatrienoic acids constrict isolated pressurized rabbit pulmonary arteries. 2000; pp. L335\u201343.","DOI":"10.1152\/ajplung.2000.278.2.L335"},{"key":"3172_CR175","doi-asserted-by":"crossref","unstructured":"Ma J, Zhang L, Li S, Liu S, Ma C, Li W, Falck JR, Manthati VL, Reddy DS, Medhora M, Jacobs ER, Zhu D. 8,9-Epoxyeicosatrienoic acid analog protects pulmonary artery smooth muscle cells from apoptosis via ROCK pathway. pp. 2340\u201353.","DOI":"10.1016\/j.yexcr.2010.05.013"},{"key":"3172_CR176","doi-asserted-by":"crossref","unstructured":"Loot AE, Moneke I, Keser\u00fc B, Oelze M, Syzonenko T, Daiber A, Fleming I. 11,12-EET stimulates the association of BK channel \u03b1 and \u03b2(1) subunits in mitochondria to induce pulmonary vasoconstriction. 2012; p. e46065.","DOI":"10.1371\/journal.pone.0046065"},{"key":"3172_CR177","doi-asserted-by":"crossref","unstructured":"Kandhi S, Zhang B, Froogh G, Qin J, Alruwaili N, Le Y, Yang Y-M, Hwang SH, Hammock BD, Wolin MS, Huang A, Sun D. EETs promote hypoxic pulmonary vasoconstriction via constrictor prostanoids. 2017; pp. L350\u20139.","DOI":"10.1152\/ajplung.00038.2017"},{"key":"3172_CR178","doi-asserted-by":"crossref","unstructured":"Loot AE, Fleming I. Cytochrome P450-derived epoxyeicosatrienoic acids and pulmonary hypertension: central role of transient receptor potential C6 channels. 2011; pp. 140\u20137.","DOI":"10.1097\/FJC.0b013e3181ed088d"},{"key":"3172_CR179","doi-asserted-by":"crossref","unstructured":"Keser\u00fc B, Barbosa-Sicard E, Popp R, Fisslthaler B, Dietrich A, Gudermann T, Hammock BD, Falck JR, Weissmann N, Busse R, Fleming I. Epoxyeicosatrienoic acids and the soluble epoxide hydrolase are determinants of pulmonary artery pressure and the acute hypoxic pulmonary vasoconstrictor response. 2008; pp. 4306\u201315.","DOI":"10.1096\/fj.08-112821"},{"key":"3172_CR180","doi-asserted-by":"crossref","unstructured":"Kandhi S, Froogh G, Qin J, Luo M, Wolin MS, Huang A, Sun D. EETs Elicit Direct Increases in Pulmonary Arterial Pressure in Mice. 2016; pp. 598\u2013604.","DOI":"10.1093\/ajh\/hpv148"},{"key":"3172_CR181","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejphar.2014.01.045","volume":"727","author":"JX Jiang","year":"2014","unstructured":"Jiang JX, Zhang SJ, Liu YN, Lin XX, Sun YH, Shen HJ, Yan XF, Xie QM. EETs alleviate ox-LDL-induced inflammation by inhibiting LOX-1 receptor expression in rat pulmonary arterial endothelial cells. Eur J Pharmacol. 2014;727:43\u201351.","journal-title":"Eur J Pharmacol"},{"key":"3172_CR182","doi-asserted-by":"crossref","unstructured":"Singh TU, Choudhury S, Parida S, Maruti BS, Mishra SK. Arachidonic acid inhibits Na\u207a-K\u207a-ATPase via cytochrome P-450, Lipoxygenase and protein kinase C-dependent pathways in sheep pulmonary artery. 2012; pp. 84\u201390.","DOI":"10.1016\/j.vph.2011.11.005"},{"key":"3172_CR183","doi-asserted-by":"crossref","unstructured":"Yaghi A, Sims SM. Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle. Am J Physiol Lung Cell Mol Physiol 2005: 289(6): L1061\u201374.","DOI":"10.1152\/ajplung.00096.2005"},{"issue":"3","key":"3172_CR184","doi-asserted-by":"publisher","first-page":"L369","DOI":"10.1152\/ajplung.00265.2004","volume":"291","author":"ER Jacobs","year":"2006","unstructured":"Jacobs ER, Zhu D, Gruenloh S, Lopez B, Medhora M. VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P-450 hydroxylase. Am J Physiol Lung Cell Mol Physiol. 2006;291(3):L369\u201377.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"3","key":"3172_CR185","doi-asserted-by":"publisher","first-page":"L378","DOI":"10.1152\/ajplung.00424.2005","volume":"291","author":"Y Chen","year":"2006","unstructured":"Chen Y, Medhora M, Falck JR, Pritchard KA, Jacobs ER. Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2006;291(3):L378\u201385.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"3172_CR186","doi-asserted-by":"publisher","first-page":"L564","DOI":"10.1152\/ajplung.00298.2009","volume":"298","author":"S Bodiga","year":"2010","unstructured":"Bodiga S, Gruenloh SK, Gao Y, Manthati VL, Dubasi N, Falck JR, Medhora M, Jacobs ER. 20-HETE-induced nitric oxide production in pulmonary artery endothelial cells is mediated by NADPH oxidase, H2O2, and PI3-kinase\/Akt. Am J Physiol Lung Cell Mol Physiol. 2010;298(4):L564\u201374.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"4","key":"3172_CR187","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1152\/japplphysiol.00247.2002","volume":"93","author":"M Yu","year":"2002","unstructured":"Yu M, McAndrew RP, Al-Saghir R, Maier KG, Medhora M, Roman RJ, Jacobs ER. Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries. J Appl Physiol (Bethesda Md: 1985). 2002;93(4):1391\u20139.","journal-title":"J Appl Physiol (Bethesda Md: 1985)"},{"key":"3172_CR188","doi-asserted-by":"crossref","unstructured":"Sugumaran P, Narayanan V, Zhu D, Medhora M, Jacobs ER, Chandramohan Y, Selvaraj V, Dhanasekaran A. Prophylactic supplementation of 20-HETE ameliorates hypoxia\/reoxygenation injury in pulmonary vascular endothelial cells by inhibiting apoptosis. 2020; p. 151461.","DOI":"10.1016\/j.acthis.2019.151461"},{"issue":"3","key":"3172_CR189","doi-asserted-by":"publisher","first-page":"H777","DOI":"10.1152\/ajpheart.01087.2008","volume":"296","author":"A Dhanasekaran","year":"2009","unstructured":"Dhanasekaran A, Bodiga S, Gruenloh S, Gao Y, Dunn L, Falck JR, Buonaccorsi JN, Medhora M, Jacobs ER. 20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cells. Am J Physiol Heart Circ Physiol. 2009;296(3):H777\u201386.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3172_CR190","doi-asserted-by":"crossref","unstructured":"Wang Z, Tang X, Li Y, Leu C, Guo L, Zheng X, Zhu D. 20-Hydroxyeicosatetraenoic acid inhibits the apoptotic responses in pulmonary artery smooth muscle cells. Eur J Pharmacol 2008: 588(1).","DOI":"10.1016\/j.ejphar.2008.03.045"},{"key":"3172_CR191","doi-asserted-by":"crossref","unstructured":"Wang J, Lian G, Luo L, Wang T, Xu C, Wang H, Xie L. Role of 20-hydroxyeicosatetraenoic acid in pulmonary hypertension and proliferation of pulmonary arterial smooth muscle cells. 2020; p. 101948.","DOI":"10.1016\/j.pupt.2020.101948"},{"key":"3172_CR192","doi-asserted-by":"crossref","unstructured":"Medhora M, Chen Y, Gruenloh S, Harland D, Bodiga S, Zielonka J, Gebremedhin D, Gao Y, Falck JR, Anjaiah S, Jacobs ER. 20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells. Am J Physiol Lung Cell Mol Physiol 2008: 294(5): L902\u201311.","DOI":"10.1152\/ajplung.00278.2007"},{"issue":"9","key":"3172_CR193","doi-asserted-by":"publisher","first-page":"H1107","DOI":"10.1152\/ajpheart.00961.2015","volume":"310","author":"A Lakhkar","year":"2016","unstructured":"Lakhkar A, Dhagia V, Joshi SR, Gotlinger K, Patel D, Sun D, Wolin MS, Schwartzman ML, Gupte SA. 20-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase Inhibition. Am J Physiol Heart Circ Physiol. 2016;310(9):H1107\u201317.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3172_CR194","doi-asserted-by":"crossref","unstructured":"Lakhkar A, Dhagia V, Joshi SR, Gotlinger K, Patel D, Sun D, Wolin MS, Schwartzman ML, Gupte SA. 20-HETE-induced mitochondrial superoxide production and inflammatory phenotype in vascular smooth muscle is prevented by glucose-6-phosphate dehydrogenase Inhibition. 2016; pp. H1107\u201317.","DOI":"10.1152\/ajpheart.00961.2015"},{"key":"3172_CR195","doi-asserted-by":"crossref","unstructured":"Chawengsub Y, Gauthier KM, Campbell WB. Role of arachidonic acid Lipoxygenase metabolites in the regulation of vascular tone. 2009; pp. H495\u2013507.","DOI":"10.1152\/ajpheart.00349.2009"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03172-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-025-03172-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-025-03172-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T19:47:38Z","timestamp":1742068058000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-025-03172-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":195,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3172"],"URL":"https:\/\/doi.org\/10.1186\/s12931-025-03172-2","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,15]]},"assertion":[{"value":"6 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare that they have no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"102"}}